Orthofix Medical trades at an attractive valuation with a strong earnings beat streak, but a confirmed technical downtrend and weak growth via a Rule of 40 failure keep the setup speculative despite offsetting free cash flow generation.
Thesis pillars
- Elevated Implied Volatility Earnings Risk→Stable
- Confirmed Downtrend Death Cross→Stable
- Attractive Valuation Earnings Beat→Stable
- +2 more pillars — see the Why tab for full reasoning
Orthofix Medical Inc. (OFIX) Stock Analysis
Falling Knife setup
Healthcare · Medical Devices
Sell if holding. Engine safety override at $10.22: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend.
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The... Read more
Sell if holding. Engine safety override at $10.22: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: Death cross, below all MAs, RSI 29, MACD bearish. Score 4.6/10, moderate confidence.
Passes 3/8 gates (earnings proximity 80d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity and death cross (50MA < 200MA). Suitability: aggressive.
Recent developments
updated 2026-08-14Recent Developments — Orthofix Medical Inc.
Latest news
- NEWS Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - TradingView — TradingView negative
- NEWS Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - tradingview.com — tradingview.com negative
- NEWS Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for - ca.finance.yahoo.com — ca.finance.yahoo.com negative
- NEWS Orthofix Medical Inc (OFIX) Institutional Confidence - TradingKey — TradingKey neutral
- NEWS Orthofix Medical Inc (OFIX) Institutional Confidence - tradingkey.com — tradingkey.com neutral
Generated 2026-08-14T16:37:44Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductGlobal Spine segment84%10-K Item 1: 'Global Spine and Global Limb Reconstruction (formerly "Global Orthopedics"), which accounted for 84% and 16% of our total net sales in 2025, respectively'
- MEDIUMSupplierhuman cadaveric tissue supplier10-K Item 1A: 'our ability to market the tissues depends on our supplier continuing to have access to donated human cadaveric tissue'
Material Events(8-K, last 90d)
- 2026-06-11Item 5.02LOWShareholders approved Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan at the June 10, 2026 Annual Meeting, increasing shares available for issuance by 1,250,000. Routine compensatory plan amendment, not an executive departure.SEC filing →
- 2026-04-09Item 5.02MEDIUMMax Reinhardt, President of Global Spine, will depart as an executive and employee on or about June 12, 2026, treated as termination without cause or resignation for good reason under his change-in-control agreement. No successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $10.22: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.6/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: Death cross, below all MAs, RSI 29, MACD bearish. Prior stop was $9.66. Score 4.6/10, moderate confidence.
Take-profit target: $11.05 (+8.2% upside). Prior stop was $9.66. Stop-loss: $9.66.
Concentration risk — Product: Global Spine segment (84.0%); Quality below floor (4.0 < 4.0).
Orthofix Medical Inc. trades at a P/E of N/A (forward 27.5). TrendMatrix value score: 5.2/10. Verdict: Sell.
11 analysts cover OFIX with a consensus score of 4.1/5. Average price target: $13.
What does Orthofix Medical Inc. do?Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States,...
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.